Zenith(R) Low Profile AAA Endovascular Graft Clinical Study

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Cook
ClinicalTrials.gov Identifier:
NCT00833924
First received: January 30, 2009
Last updated: January 28, 2016
Last verified: January 2016

January 30, 2009
January 28, 2016
May 2008
October 2011   (final data collection date for primary outcome measure)
  • Patients With Major Adverse Events (MAE) [ Time Frame: 30-day ] [ Designated as safety issue: Yes ]
    MAE is defined as any occurrence of all-cause death, Q-wave myocardial infarction (MI), renal failure requiring dialysis, paralysis, stroke, bowel ischemia, or re-intubation.
  • Patients With Device Failures [ Time Frame: 12-month ] [ Designated as safety issue: No ]

    Device success at 12-month is defined as:

    Technical Success (successful access of the aneurysm site, deployment of the graft in the intended location, and patency of the graft at the time of deployment completion intra-operatively), and freedom from the following at 12 months: Type I or type III endoleaks requiring re-intervention, Aneurysm rupture or conversion to open surgical repair, and Aneurysm enlargement greater than 0.5 cm.

Adverse events and device success. [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00833924 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Low Profile AAA Endovascular Graft
The Zenith® Low Profile AAA Endovascular Graft Clinical Study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Low Profile AAA Endovascular Graft to treat abdominal aortic, aorto-iliac, and iliac aneurysms.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Abdominal Aortic Aneurysms
  • Iliac Aneurysms
  • Aorto-iliac Aneurysms
Device: Zenith(R) Low Profile AAA Endovascular Graft
The Zenith(R) Low Profile AAA Endovascular Graft and ancillary components are indicated for the endovascular treatment of patients with abdominal aortic, aorto-iliac, or iliac aneurysms having morphology suitable for endovascular repair.
1
Treatment with Endovascular Graft
Intervention: Device: Zenith(R) Low Profile AAA Endovascular Graft
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
120
January 2016
October 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Abdominal aortic, aortoiliac, and iliac aneurysms of appropriate size
  • Vessels suitable for endovascular access and aneurysm repair

Exclusion Criteria:

  • Less than 18 years of age
  • Inability or refusal to give informed consent
  • Disease considerations that would compromise patient safety or study outcomes
  • Unsuitable arterial anatomy
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States,   China,   Germany,   Russian Federation,   Sweden
Canada,   Ireland
 
NCT00833924
08-013, 370016
Not Provided
Not Provided
Not Provided
Cook
Cook
Not Provided
Principal Investigator: Ronald Fairman, MD University of Pennsylvania
Cook
January 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP